SCHNETTLER THOMAS P 4
4 · Akoya Biosciences, Inc. · Filed May 25, 2021
Insider Transaction Report
Form 4
SCHNETTLER THOMAS P
Director
Transactions
- Award
Stock Option (Right to Buy
2021-05-21+16,860→ 16,860 totalExercise: $21.95Exp: 2031-05-21→ Common Stock (16,860 underlying)
Holdings
- 2,813,771(indirect: Held by Piper Sandler Merchant Banking Fund II, L.P.)
Common Stock
Footnotes (2)
- [F1]PSC Capital Management II LLC is the general partner of Piper Sandler Merchant Banking Fund II, L.P. Piper Sandler Companies is the manager of PSC Capital Management II LLC. The reporting person is the Co-CEO of PSC Capital Management II LLC and disclaims beneficial ownership of the shares held by Piper Sandler Merchant Banking Fund II, L.P.
- [F2]Subject to the reporting person's continuous service through the vesting date, the options shall vest in full on the earlier of (a) May 21, 2022, or (b) the date of the next annual meeting of Akoya Biosciences, Inc. occurring after the date of grant.